Blood test may predict hodgkin relapse in kids

NCT ID NCT07356882

Recruiting now Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jan 22, 2026 · Last updated Apr 30, 2026 · Updated 12 times

Summary

This study is looking at whether a blood test that detects tumor DNA (called ctDNA) can help predict if Hodgkin lymphoma will come back in children and young adults under 25. Researchers will follow 400 participants over time to see if ctDNA levels at diagnosis and during treatment can identify those at higher risk of relapse. The goal is to improve treatment decisions and reduce side effects for those who need less intensive therapy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLASSICAL HODGKIN LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Pediatric Hematology and Oncology Department
RECRUITING

Paris, 75012, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CLASSICAL HODGKIN LYMPHOMA CLASSICAL HODGKIN LYMPHOMA